Related Experiment Video
Updated: Jan 19, 2026
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
The ubiquitin ligase adaptor SPOP in cancer
Matthew J Cuneo1, Tanja Mittag1
1Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Abstract:
The dysregulation of ubiquitin-mediated proteasomal degradation has emerged as an important mechanism of pathogenesis in several cancers. The speckle-type POZ protein (SPOP) functions as a substrate adaptor for the cullin3-RING ubiquitin ligase and controls the cellular persistence of a diverse array of protein substrates in hormone signalling, epigenetic control and cell cycle regulation, to name a few. Mutations in SPOP and the resulting dysregulation of this proteostatic pathway play causative roles in the pathogenesis of prostate and endometrial cancers, whereas overexpression and mislocalization are associated with kidney cancer. Understanding the molecular mechanism of the normal function of SPOP as well as the cause of SPOP-mediated oncogenesis is thus critical for eventual therapeutic targeting of SPOP and other related pathways. Here, we will review SPOP structure, function and the molecular mechanism of how this function is achieved. We will then review how mutations and protein mislocalization contribute to cancer pathogenesis and will provide a perspective on how SPOP may be targeted therapeutically.
Insights
Dysregulation of the speckle-type POZ protein (SPOP) pathway drives cancer. Understanding SPOP
Area of Science:
- Molecular Biology
- Cancer Pathogenesis
- Ubiquitin-Proteasome System
Background:
- Ubiquitin-mediated proteasomal degradation is crucial in cancer development.
- Speckle-type POZ protein (SPOP) acts as a substrate adaptor for cullin3-RING ubiquitin ligase.
- SPOP regulates protein stability in hormone signaling, epigenetics, and cell cycle control.
Purpose of the Study:
- To review the structure and function of SPOP.
- To elucidate the molecular mechanisms of SPOP's role in cancer.
- To explore therapeutic strategies targeting SPOP in oncogenesis.
Main Methods:
- Literature review of SPOP structure and function.
- Analysis of SPOP mutations and mislocalization in cancer.
- Review of SPOP-mediated oncogenesis mechanisms.
Main Results:
- SPOP dysregulation is implicated in prostate, endometrial, and kidney cancers.
- Mutations and mislocalization of SPOP contribute to cancer pathogenesis.
- SPOP's role in protein degradation is critical for cellular homeostasis.
Conclusions:
- Understanding SPOP's normal function and oncogenic mechanisms is vital.
- Targeting SPOP and related pathways offers potential therapeutic avenues.
- Further research into SPOP's structure-function relationship is warranted.
Related Concept Videos
06:06In Vitro Analysis of E3 Ubiquitin Ligase Function
10:27Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta
09:47Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
06:30Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
09:00Detection of Protein Ubiquitination
10:44Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs